Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 9—September 2009


Gordonia sputi Bacteremia

Aurélie Renvoise, Jean-Robert Harle, Didier Raoult, and Véronique RouxComments to Author 
Author affiliations: Hôpital de la Timone, Marseille, France (A. Renvoise, D. Raoult, V. Roux); Hôpital de La Conception, Marseille (J.-R. Harle)

Main Article


Summary of clinical reports involving Gordonia spp.*

Gordonia sp. Clinical findings, by system
Vascular Cutaneous ENT Nervous Osteoarticular Respiratory
G. rubripertincta Bacteremia (CVC) (2) Lung infection (2)
G. terrae Bacteremia (cholecystitis) (5); bacteremia (CVC) (2); bacteremia (CVC) (6)† Granulomatous skin lesion (2); palpebral abscess (9); granulomatous mastitis (7); mycetoma of the hand (9) Meningitis, brain abscess (2); brain abscess (2)†
G. bronchialis Bacteremia (sequestrated lung) (4) Recurrent breast abscess (7) Ventriculitis (intraventricular shunt) (6) Sternal wound infections (2)
G. polyisoprenivorans Endocarditis (CVC) (3);† bacteremia (CVC) (3)†
G. otitidis Bacteremia (CVC) (6) Otitis externa (6) Bronchitis (8)
G. sputi Bacteremia (CVC) (2)†; endocarditis (CVC) (2); mediastinitis (surgery) (2)
G. araii Arthritis (bioabsorbable tapered screw) (10)

*ENT, ear, nose, throat; CVC, central venous catheter. Patients were immunocompetent unless otherwise noted. When infection was associated with a medical device, the device is listed in parentheses.
†Immunocompromised patient.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO